Legal technology platform CannaRegs is on a mission to make sense of the legal landscape of marijuana for stakeholders in this growing space. The company's founder and CEO Amanda Ostrowitz explains the regulatory landscape for marijuana, and why she was inspired to launch this start-up.
"I realized the only solution to my problem was to build it," says Ostrowitz. "It's actually kind of influencing the way law is being made because we've been able to track it to such a level where the first time a city government even talks about cannabis--we've tracked it."
Ostrowitz says more than a dozen county governments in California are using the CannaRegs platform. "California is still figuring everything out, and there's a lot of opportunity. With a lot of opportunity there's a lot of risk--a lot of reward," says Ostrowitz.
Former Medtronic CEO and author of 'True North' Bill George explains the steps Boeing leadership must take to regain client and consumer trust after 737 Max 9 production was stopped.
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
To celebrate Flutter Entertainment's debut on the NYSE, FanDuel CEO Amy Howe shares her thoughts on the company's plans for growth, the future of online sportsbetting, and Super Bowl Sunday.
Investopedia's Caleb Silver shares thoughts on the upcoming Fed meeting, why individual investors are still slightly skeptical, and what he's looking for from mega cap tech earnings.
Season's greetings! Tax season, that is. January 29 is the first day you can file your tax return. We walk you through each step — plus a checklist you can download.
The Q-Collar helps protect athletes from impact-related concussions. Now, the U.S. Army is evaluating if the device could help reduce traumatic brain injury cased by blast weapons.
Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an eye for accessibility.
Mario Veneroso, Kingsview Asset Management Partner, weighs in on the latest economic data and whether the market is pricing in too many rate cuts for the coming year.
